Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents

Grants

Funding Acknowledgements

The support of the Australian Institute of Nuclear Science and Engineering is acknowledged. TCK was the recipient of AINSE awards. The Epigenomic Medicine Laboratory is supported by the Australian Research Council Future Fellowship and McCord Research. The Allergy and Immune Disorders Laboratory is supported by MCRI, and PVL is the recipient of an Australian National Health and Medical Research Council training fellowship. Both laboratories are supported in part by the Victorian government's Operational Infrastructure Support Program.